Two ISGlobal researchers have received awards at the second edition of the Campus Clínic Innovation Awards, which aim to promote innovation in the health sector. Ana Requena-Méndez has been awarded for the ISMiHealth project and Xavier Fernàndez-Busquets has won a prize for the PATAPAM project.
Ana Requena-Méndez is a physician specialising in Infectious Diseases and currently heads the Migrant Health research area at ISGlobal. The ISMihealth (CRIBMI) project, which has won one of the CATI Awards, has designed an innovative and effective digital tool to improve the health screening of migrants. Specifically, the programme is aimed at screening for infectious diseases such as HIV, tuberculosis and Chagas disease, as well as female genital mutilation (FGM) and mental health in primary care.
Xavier Fernández-Busquets, head of the Nanomalaria group at the Institute for Bioengineering of Catalonia (IBEC) and ISGlobal, has been awarded the "la Caixa" Foundation prize. The PATAPAM project has developed a protein aggregation inhibitor as a theranostic antiplasmodial agent for malaria therapy following the administration of artemisinin, one of the most common antimalarial drugs.
The ISGlobal researcher Ethel Sequeira collected the award on behalf of Ana Requena. Francisco Avia / Hospital Clínic
The Campus Clínic Innovation Awards
Innovation in the health sector is a key driver for the continuous improvement of healthcare for citizens. For this reason, the Hospital Clínic is promoting the Campus Clínic Innovation Awards, this year being the second edition.
The proposals submitted have been evaluated by 19 experts from various fields in the health sector and linked to the activities of the Campus Clínic, including Marina Espriu, from the ISGlobal Innovation team. A total of 14 proposals were shortlisted and, of these, eight were the winners.
The projects were evaluated according to the criteria of importance of the problem, solution, potential impact, scalability, degree of innovation and feasibility. Each prize is endowed with 25,000 euros, an amount that will serve to advance the innovation presented in the market.